TWI670093B - Medicament volatilizer - Google Patents

Abstract

An object of the present invention is to provide a drug volatilizer which can completely use up the medicine in the container even when a rod-shaped volatilizer is used.

The present invention has an inner space surrounded by a bottom wall portion and a peripheral wall portion, and an opening having an opening in the upper portion, the inner space for receiving a liquid medicine container, and a manner in which one end portion protrudes from the opening. a plurality of rod-shaped volatility bodies that are inserted into the internal space from the opening; the container is configured such that a line connecting the peripheral edge of the inner wall surface of the bottom wall portion and the inner circumference of the opening is located in the internal space, and the The bottom wall portion has a raised portion that is raised from the peripheral edge of the inner wall surface of the bottom wall portion toward the center.

Description

Medicament volatilizer

The invention relates to a medicament volatilizer.

Conventionally, various types of fragrance devices have been proposed. For example, Patent Document 1 discloses that a liquid drug is contained in a container having an opening at the upper portion, and a plurality of rod-shaped volatilized bodies are inserted from the opening of the container to be immersed in the drug. Drug volatilizer. In the medicine vagor, the medicine is further volatilized to the outside via the rod-shaped volatile body to obtain a fragrance effect.

[Previous Technical Literature] [Patent Literature]

[Patent Document 1] Japanese Patent Laid-Open Publication No. 2011-4867

However, as with the medicament volatilizer described above, it may not be possible to use up all of the medicament in the container. That is, since the volatilized body is formed in a rod shape, even if a plurality of volatilized bodies are used, it is not possible to arrange the entire bottom surface of the container. Therefore, it is impossible to absorb the residual in the unconfigured volatilized body. Part of the medicament, and there is a problem that the medicament remains in the container. The present invention has been made to solve the above problems, and an object thereof is to provide a medicine volatilizer which can completely use up the medicine in the container even when a rod-shaped volatile body is used.

The present invention has an internal space surrounded by a bottom wall portion and a peripheral wall portion, and further includes: a container having an opening at an upper portion and accommodating a liquid medicine in the internal space; and one end portion of the container protrudes from the opening a plurality of rod-shaped volatility bodies that are inserted into the internal space from the opening, and the container is configured such that a line connecting the peripheral edge of the inner wall surface of the bottom wall portion and the inner periphery of the opening is located in the internal space. The bottom wall portion has a raised portion that is raised from the peripheral edge of the inner wall surface of the bottom wall portion toward the center.

According to this configuration, the bulging portion which is bulged from the peripheral edge toward the center is disposed on the inner wall surface of the bottom wall portion of the container, and the liquid medicine is accumulated on the periphery of the bottom wall portion. Further, by the bulging portion, since the rod-shaped volatilized body is positioned at the end portion inside the container, it is inclined downward and moved to the periphery of the bottom wall portion, so that the remaining drug can be contacted. Therefore, even if the residual amount of the drug is small, the volatilized body is also exposed to the drug, and the drug is completely used up.

In the above-described drug volatilizer, the ridge portion may have various shapes. For example, the bottom wall may be formed in a circular shape, and the ridge portion may be formed in a dome shape. In this way, since the ridge portion is formed by the curved surface, the end portion of the volatility body easily moves along the inclined surface. Further, the ridge portion may be formed in various shapes such as a conical shape or a polygonal pyramid shape.

The container of the present invention may be configured such that a straight line connecting the peripheral edge of the inner wall surface of the bottom wall portion and the inner peripheral edge of the opening is located in the internal space. In the above case, the container may be in various forms, for example, the peripheral wall portion. The outer shape may be formed by a tapered shape in which the bottom wall portion is tapered toward the opening.

In the above-mentioned drug volatilizer, the minimum outer diameter of the bottom wall portion is R, the angle between the straight line connecting the peripheral edge of the inner wall surface of the bottom wall portion and the inner periphery of the opening, and the bottom wall portion are θ, and the length of the volatilized body is When L, it can be R≧LCOSθ. In this way, the end portion of the volatilized body protruding from the container opening can be prevented from protruding to the outside from the bottom wall portion of the container when viewed in plan. That is, it is possible to prevent the end portion of the volatilized body from protruding to the outside of the smallest outer diameter of the container. Thereby, for example, when the medicine vagating device is disposed in a narrow region surrounded by a wall, furniture, or the like, the end portion of the volatilized body can be prevented from contacting the wall or the like. As a result, it is possible to prevent the drug from adhering to the wall or the like via the volatilized body.

At this time, θ is preferably 45° or more and 85° or less. When θ is 45° or more, the volatilized body can be exposed to the outside of the container at a specific length or more, and when θ is 85° or less, since the inclination of the volatilized body is large, the lower end portion of the volatilized body is likely to be on the inner wall surface of the bottom wall portion. Peripheral movement.

The above-mentioned drug volatilizer is not particularly limited to the material forming the container, but may be formed, for example, of glass. As a result, the volatility body slides more easily, and the end portion of the volatility body easily moves along the ridge portion to the periphery of the bottom wall portion. As a result, since the drug having a small residual amount is easily exposed to the volatilized body, the drug can be completely used up.

The above-mentioned medicine volatilizer can form the above-mentioned volatilized body using various materials, for example, can be formed by rattan.

According to the medicine vagating device of the present invention, even when a stick-shaped volatilized body is used, all the medicines in the container can be used up.

1‧‧‧ container

2‧‧‧ volatility

11‧‧‧ bottom wall

12‧‧‧Walls

13‧‧‧ openings

111‧‧‧Uplift

Fig. 1 is a perspective view of a medicament volatilizer according to an embodiment of the present invention.

Figure 2 is a cross-sectional view of Figure 1.

Fig. 3 is a cross-sectional view showing the state of use of the medicine dissipator of Fig. 1.

Fig. 4 is a cross-sectional view showing an example of a container which is not a container of the present invention.

Fig. 5 is a cross-sectional view showing another example of the container of the present invention.

Fig. 6 is a plan view showing the inner wall surface of the bottom wall portion of another example of the container of the present invention.

Hereinafter, an embodiment in which the drug vaporizer of the present invention is applied to a vulcanizer of a fragrance will be described with reference to the drawings. Fig. 1 is a perspective view of a drug vaporizer according to the present embodiment, and Fig. 2 is a cross-sectional view of Fig. 1 .

As shown in Figs. 1 and 2, the drug vagating device is composed of a container 1 containing a liquid drug and a volatilized body 2 inserted into the container 1. The container 1 is composed of a bottom wall portion 11 and an outer diameter from the bottom The peripheral portion of the wall portion 11 is formed by a tapered peripheral wall portion 12 which is reduced in size upward, and is formed in a conical shape as a whole. Next, at the upper end of the peripheral wall portion 12, a circular opening 13 is formed which communicates with the internal space.

On the outer peripheral surface of the peripheral wall portion 12, a plurality of annular projections 121 along the circumferential direction are formed. The projections 121 are formed in the vertical direction at a predetermined interval, and are formed in the upper and lower directions of the peripheral wall portion 12. Further, among the projections 121, the plurality of projections 121a disposed in the vicinity of the opening 13 have a height from the outer peripheral surface larger than the height of the other projections 121. Therefore, the anti-slip effect of the protrusion 121 is improved, and the container 1 can be easily held by a finger or the like.

The inner wall surface of the bottom wall portion 11 has a circular shape when viewed in plan, and is formed with a dome-shaped bulging portion 111 which is raised from the periphery thereof toward the center. That is, the inner wall surface of the bottom wall portion 11 is raised upward in the center, and its height is lowered as it approaches the circumference. Further, the angle of the inclined surface of the ridge portion 111 is, as will be described later, for the purpose of easily sliding the volatility body 2, and may be, for example, 2 to 15 degrees. Further, when the raised portion 111 is inclined into a curved shape, as shown in Fig. 2, the inclination angle is an angle α between the tangent to the inclined surface and the horizontal plane. Further, the inclination angle is not necessarily an angle of the above range in all the portions of the raised portion 111, and may be an inclined surface at an angle of the above range in any of the portions.

The container 1 as shown above may be formed of various materials such as glass or plastic. However, if it is formed of glass, as will be described later, the volatilized body 2 is more likely to slide. In addition, the medicine contained in the container 1 As the agent, a fragrance, a deodorant, an aromatic oil, or the like can be used, and the entire drug can be impregnated into the volatilized body 2 and volatilized to the outside.

Next, the description will be given of the volatilized body 2. The volatilized body 2 is inserted into the opening 13 of the container 1 and formed into a rod shape. The volatilized body 2 is not particularly limited as long as it can absorb and scatter the drug, and can be formed, for example, from natural materials such as reed, bamboo, and rattan. Further, the length of the volatilized body 2 can be specified as follows. As shown in Fig. 2, the lower end portion of the diffuser 2 is disposed on the peripheral edge of the inner wall surface of the bottom wall portion 11, and when the upper end portion protrudes outward from the opening 13 of the container 1, the length L of the diffuser 2 is volatilized. The relationship between the angle θ with respect to the horizontal plane and the minimum outer diameter R of the bottom wall portion 11 is preferably R ≧ Lcos θ. When the regulation is made in this manner, the upper end portion of the volatilized body 2 can be prevented from protruding further to the outer side than the bottom wall portion 11 of the container 1 when viewed in plan. Thereby, for example, when the medicine vagator is disposed in a narrow area surrounded by a wall or furniture, the upper end portion of the volatilized body 2 can be prevented from contacting the wall. Further, θ is preferably 45° or more and 85° or less. When θ is 45° or more, when the volatilized body 2 is not excessively long, the volatilized body 2 can be exposed to the outside of the container 1 with a certain length or more, and θ is 85° or less because of the volatilization body 2 The inclination is large, and as will be described later, the lower end portion of the volatilized body 2 is easily moved to the periphery of the inner wall surface of the bottom wall portion 11. That is, the swinging body 2 is easily moved to the periphery by the force of the tilt.

Next, the method of using the drug vagating device having the above configuration will be described with reference to Fig. 3 as well. First, the medicament is injected into the container 1 from the opening 13. Pharmacy, not pre-contained in container 1 In the inside, it is stored in a sealed state in another drug container (not shown), and when it is used, it is moved to the container 1. Next, the plurality of volatilized bodies 2 are inserted from the opening 13 of the container 1 and immersed in the medicine. Thereby, the medicine moves upward and volatilizes to the outside via the volatilization body 2. In this way, the aroma effect of the drug, the deodorizing effect, and the like can be obtained.

Further, when the medicine is continuously volatilized, the medicine in the container 1 is reduced because the bulge portion 111 is formed on the inner wall surface of the bottom wall portion 11 of the container 1, and at the end of use, the medicine is applied to the periphery of the inner wall surface at the inclination of the ridge portion 111. mobile. Therefore, as shown in Fig. 3, the amount of the drug having a reduced amount is accumulated in the vicinity of the periphery of the inner wall surface. Further, the lower end portion of the volatility body 2 slides over the inclined surface of the ridge portion 111 and moves toward the periphery of the inner wall surface. Thereby, since the lower end portion of the volatilized body 2 contacts the drug, the remaining amount of the drug and the volatilized body 2 can be maintained in a contact state. Therefore, the medicament can be completely used up.

Further, in the present embodiment, since the medicine sealed in the other drug container is transferred to the container 1 and used, it is not necessary to install a cap, a lid, or the like for sealing the medicine to the container 1. Therefore, in the form of the container, it is possible to use a container of various designs which is not limited by the design of the neck. The container 1 of the present embodiment does not have a neck portion, and an opening 13 is formed at an upper end of the peripheral wall portion 12. Therefore, in the present embodiment, it is not necessary to provide the neck portion, because the height of the container 1 corresponding to the portion can be lowered, and the volatilized body 2 can be protruded from the opening 13 for a longer length.

The above is an embodiment of the present invention, however, the present invention is not limited thereto, as long as it does not deviate from the gist thereof. Various changes can be implemented. For example, in the above embodiment, the conical container 1 is used, however, it is not limited thereto. For example, in the container of the form shown in Fig. 4, a part (S3) connecting the circumferential edge S1 of the inner wall surface of the bottom wall portion 110 and the inner circumference S2 of the opening 130 is not located in the internal space. The volatilized body 200 inserted from the opening 130 of the container 100 does not reach the periphery of the bottom wall portion 110 of the container 100. Therefore, this form has doubts that the medicine cannot be used up. Therefore, as shown in Figs. 2 and 3, the container used in the present invention must have at least a straight line connecting the peripheral edge of the inner wall surface of the bottom wall portion 11 and the inner periphery of the opening 13 in a form of being positioned in the inner space. . In this case, the shape of the container is not particularly limited, and the shape in plan view may be a polygonal shape in addition to a circular shape, or, for example, as shown in Fig. 5, the longitudinal section may be plural. The form of the combination of shapes.

Further, the bottom surface portion of the container 1 may have an elliptical shape or a polygonal shape in addition to a circular shape. Further, the shape of the raised portion 111 may be other than a dome shape, and may be, for example, a polygonal pyramid shape, and the top portion may have a sharp shape other than a curved surface.

Further, the shape of the inner wall surface of the bottom wall portion 11 and the shape of the raised portion 111 when viewed in plan are not necessarily the same. For example, as shown in Fig. 6(a), the bottom wall portion 11 may be as follows. The raised portion 111 has a circular shape, or as shown in Fig. 6(b), the bottom wall portion 11 has a circular shape and the raised portion 111 has a hexagonal shape.

Claims (5)

A medicine vagating device comprising: a container having an inner space surrounded by a bottom wall portion and a peripheral wall portion, and having an opening at an upper portion for accommodating a liquid medicament; and a plurality of rod-shaped volatility bodies The front end portion is inserted into the internal space from the opening so that the front end portion protrudes from the opening; and the container is a line that connects the peripheral edge of the inner wall surface of the bottom wall portion and the inner peripheral edge of the opening to the inner space. The bottom wall portion has a raised portion that is raised from a peripheral edge of the inner wall surface of the bottom wall portion toward the center, and the volatilized body is disposed along the straight line in the container, and the peripheral wall portion is a tapered shape in which the outer shape gradually decreases from the bottom wall toward the opening, the minimum outer diameter of the bottom wall portion is R, a line connecting the peripheral edge of the inner wall surface of the bottom wall portion and the inner peripheral edge of the opening, and the bottom wall portion When the angle is θ and the length of the volatilized body is L, R ≧ LCOS θ. The drug volatilizer according to claim 1, wherein the bottom wall is formed in a circular shape. The raised portion is formed in a dome shape. The drug volatilizer according to claim 1, wherein the θ is 45° or more and 85° or less. The drug volatilizer according to claim 1 or 2, wherein the container is formed of glass. The drug volatilizer according to claim 1 or 2, wherein the volatilized body is formed of vine.